Oludamilola W Oluleye1, Richard A Kronmal2, Aaron R Folsom3, Dhananjay M Vaidya4, Pamela Ouyang4, Daniel A Duprez5, Adrian S Dobs4, Hirad Yarmohammadi6, Suma H Konety5. 1. Essentia Health-Fargo Heart and Vascular Center, Fargo, North Dakota. 2. Department of Biostatistics, University of Washington, Seattle, Washington. 3. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota. 4. Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. 6. Columbia University, New York, New York.
Abstract
PURPOSE: Based on the 2018 American College of Cardiology/American Heart Association cholesterol guidelines, the number of individuals eligible for statin therapy to reduce atherosclerotic cardiovascular disease risk has greatly expanded. Statins inhibit cholesterol biosynthesis, which can impair gonadal steroidogenesis. We evaluated the effect of statins on endogenous sex hormones in a large epidemiological study. METHODS: A total of 6814 Multi-Ethnic Study of Atherosclerosis (MESA) participants underwent the baseline examination. Of these, 6171 had measurements of serum sex hormones available: dehydroepiandrosterone (DHEA), SHBG, estradiol, and total and bioavailable testosterone. Multivariable linear regression models were used to assess the relationship of statin use with each sex hormone. RESULTS: A total of 345 women (17.4%) and 464 men (14.7%) were statin users (mean age, 67 years; 41% white, 29% black, 11% Chinese, and 19% Hispanic). Among the users vs nonusers of statins, the mean SHBG was 3.54 nmol/L (P < 0.01) lower in women and 3.37 nmol/L (P < 0.001) lower in men; the mean DHEA was 1.06 nmol/L (P < 0.05) lower in women and 0.70 nmol/L (P < 0.01) lower in men, after adjustment for potential confounders. With further propensity score adjustment, the mean DHEA and SHBG levels were 0.67 nmol/L (P < 0.05) and 3.49 nmol/L (P < 0.001) lower, respectively, for statin users vs nonusers. No statistically significant association was noted between estradiol, total testosterone, and bioavailable testosterone and statin use. CONCLUSION: Statin users have lower levels of SHBG and DHEA. This is especially relevant owing to the increasing use of statin therapy.
PURPOSE: Based on the 2018 American College of Cardiology/American Heart Association cholesterol guidelines, the number of individuals eligible for statin therapy to reduce atherosclerotic cardiovascular disease risk has greatly expanded. Statins inhibit cholesterol biosynthesis, which can impair gonadal steroidogenesis. We evaluated the effect of statins on endogenous sex hormones in a large epidemiological study. METHODS: A total of 6814 Multi-Ethnic Study of Atherosclerosis (MESA) participants underwent the baseline examination. Of these, 6171 had measurements of serum sex hormones available: dehydroepiandrosterone (DHEA), SHBG, estradiol, and total and bioavailable testosterone. Multivariable linear regression models were used to assess the relationship of statin use with each sex hormone. RESULTS: A total of 345 women (17.4%) and 464 men (14.7%) were statin users (mean age, 67 years; 41% white, 29% black, 11% Chinese, and 19% Hispanic). Among the users vs nonusers of statins, the mean SHBG was 3.54 nmol/L (P < 0.01) lower in women and 3.37 nmol/L (P < 0.001) lower in men; the mean DHEA was 1.06 nmol/L (P < 0.05) lower in women and 0.70 nmol/L (P < 0.01) lower in men, after adjustment for potential confounders. With further propensity score adjustment, the mean DHEA and SHBG levels were 0.67 nmol/L (P < 0.05) and 3.49 nmol/L (P < 0.001) lower, respectively, for statin users vs nonusers. No statistically significant association was noted between estradiol, total testosterone, and bioavailable testosterone and statin use. CONCLUSION: Statin users have lower levels of SHBG and DHEA. This is especially relevant owing to the increasing use of statin therapy.
Authors: Payal Kohli; David D Waters; Rita Nemr; Benoit J Arsenault; Michael Messig; David A DeMicco; Rachel Laskey; John J P Kastelein Journal: J Am Coll Cardiol Date: 2015-02-03 Impact factor: 24.094
Authors: Oludamilola W Oluleye; Richard A Kronmal; Aaron R Folsom; Dhananjay M Vaidya; Pamela Ouyang; Daniel A Duprez; Adrian S Dobs; Hirad Yarmohammadi; Suma H Konety Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson Journal: J Am Coll Cardiol Date: 2013-11-12 Impact factor: 24.094
Authors: C Noel Bairey Merz; Marian B Olson; B Delia Johnson; Vera Bittner; T Keta Hodgson; Sarah L Berga; Glenn D Braunstein; Carl J Pepine; Steven E Reis; George Sopko; Sheryl F Kelsey Journal: Am J Med Date: 2002-12-15 Impact factor: 4.965
Authors: Oludamilola W Oluleye; Richard A Kronmal; Aaron R Folsom; Dhananjay M Vaidya; Pamela Ouyang; Daniel A Duprez; Adrian S Dobs; Hirad Yarmohammadi; Suma H Konety Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: David S Lopez; Hyunkyoung Kim; Efstathia Polychronopoulou; Shaden Taha; Konstantinos K Tsilidis; Alejandro Villasante-Tezanos; M Kristen Peek; Syed Gilani; Mohit Khera; Jacques Baillargeon; Yong-Fang Kuo; Steven Canfield Journal: Cancer Epidemiol Date: 2022-05-04 Impact factor: 2.890
Authors: Edra London; Christina Tatsi; Steven J Soldin; Christopher A Wassif; Peter Backlund; David Ng; Leslie G Biesecker; Constantine A Stratakis Journal: Horm Metab Res Date: 2020-02-10 Impact factor: 2.936
Authors: Johanna Christina Penell; Mark M Kushnir; Lars Lind; Jonatan Bergquist; Jonas Bergquist; P Monica Lind; Tord Naessen Journal: Endocr Connect Date: 2021-05-13 Impact factor: 3.335
Authors: David S Lopez; Efstathia Polychronopoulou; Konstantinos K Tsilidis; Mohit Khera; L Joseph Su; Jay H Fowke; M K Peek; Yong-Fang Kuo; Kyriakos Markides; Steven Canfield Journal: Cancer Prev Res (Phila) Date: 2021-04-20
Authors: Xiaotong Ma; Shaowei Sang; Yuanyuan Zhao; Xiang Wang; Xiaokang Ji; Sai Shao; Guangbin Wang; Fuzhong Xue; Yifeng Du; Ming Lv; Qinjian Sun Journal: Front Cardiovasc Med Date: 2022-03-02
Authors: João Martin Martins; Mafalda de Pina Jorge; Catarina Martins Maia; João Roque; Carlos Lemos; Daniel Nunes; Dinis Reis; Catarina Mota Journal: Int J Endocrinol Date: 2021-06-04 Impact factor: 3.257
Authors: David S Lopez; Danmeng Huang; Konstantinos K Tsilidis; Steven Canfield; Mohit Khera; Jacques G Baillargeon; Yong-Fang Kuo; M Kristen Peek; Elizabeth A Platz; Kyriakos Markides Journal: Cancer Causes Control Date: 2021-05-26 Impact factor: 2.506